Corneal Crosslinking for Treatment of Corneal Neovascularization

Clinical trial NCT04787471 · RECRUITING

Trial details

NCT number: NCT04787471
Sponsor: Price Vision Group
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Corneal Neovascularization

Start date: 2021-05-03
Primary completion: 2026-07-15
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.